ORCHID PHARMA
Back to Balance Sheet
|
ORCHID PHARMA Last 5 Year Total Current Liabilities History
[Consolidated]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Total Current Liabilities | ₹260 Cr | ₹372 Cr | ₹241 Cr | ₹142 Cr | ₹175 Cr |
What is the latest Total Current Liabilities ratio of ORCHID PHARMA ?
Year | Total Current Liabilities |
---|---|
Mar2024 | ₹260 Cr |
Mar2023 | ₹372 Cr |
Mar2022 | ₹241 Cr |
Mar2021 | ₹142 Cr |
Mar2020 | ₹175 Cr |
How is Total Current Liabilities of ORCHID PHARMA Trending?
Years | Total Current Liabilities | % Change | |
---|---|---|---|
Mar2024 | ₹260 Cr | -30.09 | |
Mar2023 | ₹372 Cr | 54.45 | |
Mar2022 | ₹241 Cr | 69.46 | |
Mar2021 | ₹142 Cr | -18.78 | |
Mar2020 | ₹175 Cr | - |
Compare Total Current Liabilities of peers of ORCHID PHARMA
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
ORCHID PHARMA | ₹3,753.3 Cr | 3.2% | 7.2% | -33% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹408,667.0 Cr | 1.8% | 3.4% | 7.3% | Stock Analytics | |
DIVIS LABORATORIES | ₹180,131.0 Cr | -0.7% | 3.8% | 49.3% | Stock Analytics | |
CIPLA | ₹119,745.0 Cr | -0.2% | -1.1% | -2.8% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹118,603.0 Cr | 5.8% | 8.6% | 17.3% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹105,429.0 Cr | 0.7% | -3.8% | -7.3% | Stock Analytics |
ORCHID PHARMA Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
ORCHID PHARMA | 3.2% |
7.2% |
-33% |
SENSEX | -1.1% |
0.8% |
2.2% |
You may also like the below Video Courses